ArticleMedicine2026
Sarcopenia, unhealthy lifestyle, and vitamin D: A Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Observational studies have associated vitamin D deficiency with sarcopenia and lifestyle; however, the causal link between them remains unclear. This study aimed to evaluate the causal relationship between 25-hydroxyvitamin D (25(OH)D) and sarcopenia and unhealthy lifestyle using Mendelian randomization (MR). We extracted pooled data on 25(OH)D from a genome-wide association study conducted on individuals of European ancestry. Sarcopenia outcomes were assessed using appendicular lean mass, low handgrip strength, and usual walking pace. Unhealthy lifestyle outcomes were assessed using able to walk or cycle unaided for 10 minutes, moderate-to-vigorous intensity physical activity during leisure time, waist-hip ratio, alcohol consumption, and never smoked. A 2-sample MR approach was employed in this study, utilizing the inverse-variance weighted (IVW) method and the MR-Egger method as the primary research method. Heterogeneity and horizontal pleiotropy analyses were performed to ensure the stability of the candidate single-nucleotide polymorphisms as instrumental variables. The study found that a higher 25(OH)D level was associated with an increased appendicular lean mass (IVW: Beta 0.03, 95% confidence interval: 0.01-0.06, P = .011). However, this study did not provide evidence of a causal relationship between 25(OH)D levels and other muscle traits. For unhealthy lifestyle, MR-Egger analysis suggests that increased levels of 25(OH)D increase the probability of never smoked (odds ratio 1.08, 95% confidence interval: 1.03-1.11, P = .015). In addition, the study detected no pleiotropy (all P > .05), except for low hand grip strengthEuropean Working Group on Sarcopenia in Older People 2 (IVW: Q = 24.141, P = .019; MR-Egger: Q = 23.908, P = .013). This study confirms a causal relationship between 25(OH)D, sarcopenia, and smoking.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.